Tuesday 13 October 2026 Export ASMB’s income statement to Excel — free account

Assembly Biosciences, Inc.

Assembly Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $72.3 million, up 153.5% from fiscal 2024. In the quarter to June 2026, revenue grew 38.9%, EPS grew 85.0% and free cash flow grew 7.58%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

20.65 2.12 −9.31%

Follow ASMB

Alert me

Market cap: $463.6M
P/E: 22.3×
Fwd P/E: −21.1×
Dividend yield: —
F-score: 4/9
Altman Z: 1.06
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	26.94	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	6.92	6.60	5.27	8.73
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(33.45)	(21.22)	26.78	(21.46)
P/B ratio Full definition →	1.70	2.36	1.84	1.78
Price to Tangible BV Full definition →	1.96	2.99	2.31	2.30
EV/Sales Full definition →	2.64	3.41	1.84	2.48
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(5.14)	(6.10)	(3.24)	(1.65)
EV/FCF Full definition →	(5.13)	(6.08)	(3.24)	(1.65)
Quick Ratio Full definition →	13.70	6.49	5.11	4.37
Current Ratio Full definition →	13.99	6.65	5.22	4.44
Net Debt/EBITDA Full definition →	45.17	18.68	(13.06)	20.25
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.36	0.43	0.38	0.22
Operating CF/Net income Full definition →	4.02	2.43	0.64	1.65
Capex/Depreciation Full definition →	0.00	0.02	0.03	0.07
Interest Coverage Full definition →	2.55	—	—	—
Research and Development Expense of Revenue Full definition →	111.54%	181.42%	40.62%	153.74%
Selling, General and Administrative Expense of Revenue Full definition →	35.90%	57.02%	12.76%	47.13%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	18.06%	13.59%	3.44%	15.48%
Graham Net Nets Full definition →	0.58	0.42	0.53	0.55
Graham Number Full definition →	19.29	0.00	0.00	0.00
Earnings Yield Full definition →	3.71%	(0.40%)	(2.18%)	(18.71%)
Free Cash Flow Yield Full definition →	(7.44%)	(8.49%)	(10.79%)	(17.18%)
Revenue per Share Full definition →	0.71	0.49	3.79	0.85
Operating CF per Share Full definition →	(0.82)	(1.31)	1.27	(1.19)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.82)	(1.31)	1.27	(1.20)
Cash per Share Full definition →	16.99	13.41	22.13	18.33
Shareholders Equity per Share Full definition →	16.21	11.75	18.44	14.40
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	16.21	11.75	18.44	14.40
Free Cash Flow Full definition →	(15.49)	(22.12)	14.21	(15.17)
Working Capital Full definition →	304.53	197.62	205.77	183.43
Capital Expenditures Full definition →	0.00	(0.02)	(0.02)	(0.04)
Net Current Asset Value Full definition →	302.80	195.72	203.71	179.51
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	0.43	0.25	0.54	0.63
Average Payables Full definition →	0.96	1.00	0.88	1.51
Average Assets Full definition →	205.81	167.26	188.38	170.13
Average Common Equity Full definition →	161.87	112.87	120.06	104.35

Fold the line items

Columns are period end dates

Stockrow Weekly